Autoimmune Polyglandular Syndrome Type 1

被引:8
|
作者
Ponranjini, Vedeswari C. [1 ]
Jayachandran, S. [2 ]
Kayal, L. [2 ]
Bakyalakshmi, K. [2 ]
机构
[1] Sri Ramachandra Univ, Dept Oral Med & Radiol, Chennai, Tamil Nadu, India
[2] Tamilnadu Govt Dent Coll & Hosp, Dept Oral Med & Radiol, Chennai, Tamil Nadu, India
关键词
Autoimmune; candidiasis; ectodermal dystrophy; polyendocrinopathy;
D O I
10.4103/2156-7514.103018
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Autoimmune Polyglandular Syndrome (APS) Type 1 is a rare hereditary disorder that damages organs in the body. This disease entity is the result of a mutation in the AIRE gene. It is characterized by three classic clinical features - hypoparathyroidism, Addisons disease, and chronic mucocutaneous candidiasis. For a patient to be diagnosed as having APS Type 1 syndrome at least two of these features needs to be present. The third entity may develop as the disease progresses. We report a case of a 35-year-old female patient with a history of seizure from the age of 11 years, who was managed with anticonvulsant drugs. With worsening of the seizure episodes, patient was diagnosed to have hypoparathyroidism together with the manifestations of oral candidiasis, nails dystrophy, enamel hypoplasia, and hypogonadism. A diagnosis of APS-1 was considered. The facility for genetic analysis of the AIRE gene mutation was not accessible, as the test costs were prohibitive and not affordable for the patient. Patient management was directed to treating individual disease components. However, cerebral and dental changes were irreversible.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1
    Uri Pollak
    Zvi Bar-Sever
    Vered Hoffer
    Nufar Marcus
    Oded Scheuerman
    Ben Zion Garty
    European Journal of Pediatrics, 2009, 168 : 233 - 235
  • [32] A patient with autoimmune polyglandular syndrome type 1 with atypical presentation
    Bazdarska, Yuliya
    Yordanova, Nikolinka
    Hristozova, Hristina
    Krumova, Darina
    Iotova, Violeta
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 140 - 140
  • [33] Defective immunoregulation in autoimmune polyglandular syndrome type-1.
    Kukreja, A
    Ten, S
    Ramchandani, N
    Marker, J
    Andreitchouk, A
    Sinha, S
    Sun, Z
    Harbison, M
    New, M
    Maclaren, N
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S46 - S46
  • [34] Autoimmune Polyglandular Syndrome Type-1 (APS-1)
    Al-Safi, Rasha
    Al-Jalahma, Maha
    Al-Mazaidi, Zaidan
    KUWAIT MEDICAL JOURNAL, 2010, 42 (04): : 310 - 311
  • [35] Autoimmune Polyglandular Syndrome Type 1 with Clinical and Genetic Characteristics
    Subasioglu, Asli
    Gasimli, Roya
    Kalender, Derya Sema Yaman
    Pamuk, Baris Onder
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 160 - 161
  • [36] Type 1 diabetes mellitus and autoimmune polyglandular syndrome (APS)
    Badenhoop, Klaus
    Schloot, Nanette C.
    DIABETOLOGE, 2022, 18 (01): : 4 - 11
  • [37] Autoimmune polyglandular syndrome (APS) type 1 and candida onychomycosis
    Manz, B
    Scholz, GH
    Willgerodt, H
    Haustein, UF
    Nenoff, P
    EUROPEAN JOURNAL OF DERMATOLOGY, 2002, 12 (03) : 283 - 286
  • [38] Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1
    Pollak, Uri
    Bar-Sever, Zvi
    Hoffer, Vered
    Marcus, Nufar
    Scheuerman, Oded
    Garty, Ben Zion
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (02) : 233 - 235
  • [39] PPCM and type II autoimmune polyglandular syndrome
    Jolobe, Oscar M. P.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2018, 36 (12): : 2333 - 2333
  • [40] POLYGLANDULAR AUTOIMMUNE SYNDROME, TYPE-2
    LEOR, J
    LEVARTOWSKY, D
    SHARON, C
    SOUTHERN MEDICAL JOURNAL, 1989, 82 (03) : 374 - 376